-+ 0.00%
-+ 0.00%
-+ 0.00%

*Johnson & Johnson: 3Q Innovative Medicine Operational Sales Growth Partially Offset by Impact From Stelara, Simponi/Simponi Aria, Remicade, Opsumit/Opsynvi and Imbruvica >JNJ

Dow Jones·10/13/2026 10:20:00

Please log in to view news